PTC Therapeutics, Inc. (PTCT) vs Scholar Rock Holding Corporation (SRRK)
A side-by-side comparison of PTC Therapeutics, Inc. and Scholar Rock Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PTCT
PTC Therapeutics, Inc.
$63.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SRRK
Scholar Rock Holding Corporation
$42.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PTCT vs SRRK
growth of $100 · dividends reinvested · last 8yPTCT +114.8% (+10.0%/yr)SRRK +180.0% (+13.7%/yr)SRRK compounded faster over this window
PTCT SRRK
PTCT vs SRRK: by the numbers
- •PTCT is the larger company ($5.32B vs $5.09B market cap).
- •Both run net losses; SRRK's is the smaller (0.00% vs -3.80% net margin).
Metrics side by side
Valuation
| Metric | PTCT | SRRK |
|---|---|---|
| Forward P/E | 50.13 | N/A |
| P/S ratio | 5.27 | N/A |
| P/B ratio | N/A | 20.04 |
| EV / EBITDA | 28.93 | N/A |
Profitability
| Metric | PTCT | SRRK |
|---|---|---|
| Gross margin | 95.85% | 0.00% |
| Operating margin | 49.49% | 0.00% |
| Net margin | -3.80% | 0.00% |
| ROE | N/A | -161.00% |
| ROIC | 4.59% | -90.04% |
Growth (annualized)
| Metric | PTCT | SRRK |
|---|---|---|
| Revenue CAGR (5Y) | 16.41% | N/A |
| Total return CAGR (5Y) | 11.75% | 8.20% |
Frequently asked
- How have PTCT and SRRK total returns compared?
- Over the past 5 years, PTCT delivered 11.75% and SRRK delivered 8.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
PTC Therapeutics ROEScholar Rock ROEPTC Therapeutics operating marginScholar Rock operating marginPTC Therapeutics revenue growthScholar Rock revenue growthPTC Therapeutics free cash flowScholar Rock free cash flow
PTC Therapeutics & Scholar Rock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.